Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan
Conclusion
TAE for hypervascular tumors with the HepaSphere microspheres was feasible and rarely caused major adverse events.
Trial registration: This trial was registered in JAPIC Clinical Trials Information (JapicCTI-111534).
Source: Japanese Journal of Radiology - Category: Radiology Source Type: research